Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study.

Gunilla RaskAnoosheh NazemroayaMalin JanssonCharlotta WadstenGreger NilssonCarl BlomqvistLars HolmbergFredrik WärnbergMalin Sund

Published in: Breast cancer research and treatment (2022)

Stage 1 TNBC or Luminal B-like (HER2-) tumours behave more aggressively. Women with HER2+/ER+ tumours do not have an increased risk of distant metastasis or death, absent targeted treatment.

Keyphrases

lymph node
high grade
cancer therapy
estrogen receptor
combination therapy
breast cancer cells
replacement therapy
smoking cessation